What are the key questions that drug delivery developers should ask when developing drugs for folks treating chronic diseases or illnesses? The first question a company should be asking themselves is ...

PARIS--(BUSINESS WIRE)--Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) published today new data from seven abstracts to be presented at the hybrid-setting 19 th Annual European Neuroendocrine ...

To evaluate the 1-year visual outcomes and anatomic responses of Japanese patients who received intravitreal brolucizumab (IVBr) injections for polypoidal choroidal vasculopathy (PCV). This was a ...

About six years ago, I was diagnosed with prostate cancer. I chose to have a high-intensity focused ultrasound (HIFU), which ...

The newly approved Wegovy pill has sparked strong early demand, according to data from one provider, with initial figures ...

For men with high-risk prostate cancer, hormone-blocking treatment significantly improves the possibility of a good outcome ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Overall, 22 of 37 participants reported improved ...

The natural GLP-1 hormone survives in the body for only a few minutes before it is broken down. Drug developers overcome this ...

A Wegovy trial found those taking the weight loss injections had a 20% cut in the risk of major heart problems including ...